Related Experiment Videos
[Dynamic morphologic follow-up of diabetic microangiopathy]
1I. M. Sechenov Moscow Medical Academy, 119881, Moscow.
Arkhiv Patologii
|February 24, 2001
Summary
Diabetic microangiopathy progressed despite hypoglycemic treatment in 186 patients. Angioprotective drugs like ticlid, dyamicron, and dipiridamol showed some inhibition of microvessel lesion development.
Area of Science:
- Diabetology
- Vascular Biology
- Histopathology
Context:
- Investigated microangiopathy progression in diabetic patients.
- Assessed the impact of hypoglycemic treatment.
- Evaluated angioprotective agents on microvascular lesions.
Purpose:
- To determine the efficacy of standard hypoglycemic therapy in preventing diabetic microangiopathy.
- To explore the potential of angioprotectors in mitigating microvascular damage in diabetes.
Summary:
- Skin biopsies from 186 diabetic patients (Type 1 and Type 2) revealed progressive microangiopathy.
- Hypoglycemic treatments did not halt the progression of microvascular lesions.
- Angioprotective drugs (ticlid, dyamicron, dipiridamol) demonstrated a partial inhibitory effect on microvessel lesion development.
Impact:
- Highlights the limitations of current hypoglycemic treatments in preventing microvascular complications.
- Suggests a potential therapeutic role for angioprotectors in managing diabetic microangiopathy.
- Provides histopathological evidence of microvascular changes in diabetes progression.